CUTANEOUS T-CELL LYMPHOMA
Clinical trials for CUTANEOUS T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells get a navigation system to hunt down lymphoma
Disease control OngoingThis early-phase study tests a new treatment for people with Hodgkin lymphoma or cutaneous T-cell lymphoma that has not responded to standard therapy or has returned. The treatment uses a patient's own immune cells (T cells) that are genetically modified to recognize and attack c…
Matched conditions: CUTANEOUS T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
Promising drug targets rare skin cancer in chinese patients
Disease control OngoingThis study tests a drug called mogamulizumab in 23 Chinese adults with a rare type of skin cancer (mycosis fungoides or Sézary syndrome) that has not responded to prior treatment. The goal is to see if the drug can shrink or eliminate the cancer. Participants receive the drug int…
Matched conditions: CUTANEOUS T-CELL LYMPHOMA
Phase: PHASE4 • Sponsor: Kyowa Kirin China Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
Can a body wash improve skin bacteria in lymphoma patients?
Knowledge-focused ENROLLING_BY_INVITATIONThis small study looks at whether daily use of CLn Body Wash (a mild bleach solution) can change the types of bacteria on skin affected by cutaneous T-cell lymphoma, a rare cancer. Fifteen adults with active mycosis fungoides will use the wash for 8 weeks. The main goal is to see…
Matched conditions: CUTANEOUS T-CELL LYMPHOMA
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated May 17, 2026 02:06 UTC